NO20051681L - Lysaldring av hud og aktinskadebehandling - Google Patents
Lysaldring av hud og aktinskadebehandlingInfo
- Publication number
- NO20051681L NO20051681L NO20051681A NO20051681A NO20051681L NO 20051681 L NO20051681 L NO 20051681L NO 20051681 A NO20051681 A NO 20051681A NO 20051681 A NO20051681 A NO 20051681A NO 20051681 L NO20051681 L NO 20051681L
- Authority
- NO
- Norway
- Prior art keywords
- actin
- skin
- light aging
- damage treatment
- damage
- Prior art date
Links
- 102000007469 Actins Human genes 0.000 title abstract 2
- 108010085238 Actins Proteins 0.000 title abstract 2
- 230000032683 aging Effects 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002951572A AU2002951572A0 (en) | 2002-09-23 | 2002-09-23 | Repair of uv-induced damage in skin |
| AU2003900236A AU2003900236A0 (en) | 2003-01-21 | 2003-01-21 | Repair of uv-induced damage in skin |
| PCT/AU2003/001265 WO2004026274A1 (en) | 2002-09-23 | 2003-09-23 | Skin photoageing and actinic damage treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20051681L true NO20051681L (no) | 2005-04-05 |
Family
ID=32031299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20051681A NO20051681L (no) | 2002-09-23 | 2005-04-05 | Lysaldring av hud og aktinskadebehandling |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060153782A1 (cs) |
| EP (1) | EP1542654A4 (cs) |
| JP (1) | JP2006508058A (cs) |
| CA (1) | CA2499602A1 (cs) |
| CZ (1) | CZ2005181A3 (cs) |
| MX (1) | MXPA05003202A (cs) |
| NO (1) | NO20051681L (cs) |
| NZ (1) | NZ539149A (cs) |
| WO (1) | WO2004026274A1 (cs) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003259220C1 (en) | 2002-07-24 | 2017-08-24 | Australian Health & Nutrition Association Limited | Compositions and products containing enantiomeric equol, and methods for their making |
| US8668914B2 (en) | 2002-07-24 | 2014-03-11 | Brigham Young University | Use of equol for treating skin diseases |
| EP1569636B1 (en) | 2002-10-29 | 2017-12-13 | Colorado State University Research Foundation | Use of equol for treating androgen mediated diseases |
| US8580846B2 (en) | 2002-10-29 | 2013-11-12 | Brigham Young University | Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders |
| CA2564399A1 (en) * | 2004-04-28 | 2005-11-17 | Brigham Young University | Use of equol for treating skin diseases |
| US7993629B2 (en) * | 2008-12-23 | 2011-08-09 | Avon Products, Inc. | Topical compositions containing CIS-6-nonenol and its derivatives and methods for treating skin |
| CN106367478A (zh) | 2009-12-22 | 2017-02-01 | 雅芳产品公司 | 桩蛋白刺激组合物及其化妆品用途 |
| MX2020010999A (es) | 2018-04-18 | 2021-01-20 | Constellation Pharmaceuticals Inc | Moduladores de enzimas modificadoras de metilo, composiciones y usos de estos. |
| EP3797108B1 (en) | 2018-05-21 | 2022-07-20 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| PE20220562A1 (es) | 2019-07-24 | 2022-04-13 | Constellation Pharmaceuticals Inc | Formas cristalinas de 7-cloro-2-(4-(3-metoxiazetidin-1-il)ciclohexil)-2,4-dimetil-n-((6-metil-4-(metiltio)-2-oxo-1,2-dihidropiridin-3-il)metil)benzo[d][1,3]dioxol-5-carboxamida |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997039734A1 (en) * | 1996-04-23 | 1997-10-30 | The Procter & Gamble Company | Methods of regulating skin condition with centella asiatica extract |
| AUPO203996A0 (en) * | 1996-08-30 | 1996-09-26 | Novogen Research Pty Ltd | Therapeutic uses |
| JP2001511185A (ja) * | 1997-02-11 | 2001-08-07 | ザ、プロクター、エンド、ギャンブル、カンパニー | スキンライトニング組成物 |
| TWI234467B (en) * | 1997-06-04 | 2005-06-21 | Univ Michigan | Composition for inhibiting photoaging of skin |
| US6060070A (en) * | 1997-06-11 | 2000-05-09 | Gorbach; Sherwood L. | Isoflavonoids for treatment and prevention of aging skin and wrinkles |
| AUPP112497A0 (en) * | 1997-12-24 | 1998-01-22 | Novogen Research Pty Ltd | Compositions and method for protecting skin from UV induced immunosupression and skin damage |
| EP1063967B1 (en) * | 1998-03-16 | 2004-02-11 | The Procter & Gamble Company | Compositions for regulating skin appearance |
| WO1999047118A1 (en) * | 1998-03-16 | 1999-09-23 | The Procter & Gamble Company | Compositions for regulating skin appearance |
| CA2309179A1 (en) * | 1998-09-10 | 2000-03-16 | Avon Products, Inc. | Method and composition for reducing dermatological aging and for reduci ng bruising |
| AUPP868599A0 (en) * | 1999-02-15 | 1999-03-11 | Novogen Research Pty Ltd | Production of isoflavone derivatives |
| WO2002067988A2 (en) * | 2001-02-27 | 2002-09-06 | The Regents Of The University Of Michigan | Use of natural egfr inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth receptor |
| AUPR363301A0 (en) * | 2001-03-08 | 2001-04-05 | Novogen Research Pty Ltd | Dimeric isoflavones |
| DE10121375B4 (de) * | 2001-05-02 | 2014-01-16 | Beiersdorf Ag | Verwendung von Isoflavonoiden in kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe vor und Behandlung von sensibler Haut |
| DE10122342A1 (de) * | 2001-05-09 | 2002-11-14 | Beiersdorf Ag | Verwendung von Isoflavonen in kosmetischen oder dermatologischen Zubereitungen |
| FR2825277B1 (fr) * | 2001-05-30 | 2004-10-15 | Oreal | Composition cosmetique et/ou dermatologique et/ou pharmaceutique contenant au moins un compose ihnibiteur de l'enzime 3, b-hsd |
| EP1503751A4 (en) * | 2002-04-09 | 2007-08-01 | Novogen Res Pty Ltd | THERAPEUTIC PROCESSES AND COMPOSITIONS WITH ISOFLAV-3-EN AND ISOFLAVAN STRUCTURES |
| AU2003259220C1 (en) * | 2002-07-24 | 2017-08-24 | Australian Health & Nutrition Association Limited | Compositions and products containing enantiomeric equol, and methods for their making |
| AU2002951271A0 (en) * | 2002-09-06 | 2002-09-19 | Novogen Research Pty Ltd | Repair of dna mutagenic damage |
-
2003
- 2003-09-23 CZ CZ2005181A patent/CZ2005181A3/cs unknown
- 2003-09-23 US US10/528,911 patent/US20060153782A1/en not_active Abandoned
- 2003-09-23 CA CA002499602A patent/CA2499602A1/en not_active Abandoned
- 2003-09-23 MX MXPA05003202A patent/MXPA05003202A/es active IP Right Grant
- 2003-09-23 EP EP03797109A patent/EP1542654A4/en not_active Withdrawn
- 2003-09-23 WO PCT/AU2003/001265 patent/WO2004026274A1/en not_active Ceased
- 2003-09-23 JP JP2004536692A patent/JP2006508058A/ja active Pending
-
2005
- 2005-04-01 NZ NZ539149A patent/NZ539149A/en not_active IP Right Cessation
- 2005-04-05 NO NO20051681A patent/NO20051681L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20060153782A1 (en) | 2006-07-13 |
| EP1542654A1 (en) | 2005-06-22 |
| MXPA05003202A (es) | 2005-07-05 |
| CZ2005181A3 (cs) | 2005-08-17 |
| WO2004026274A1 (en) | 2004-04-01 |
| NZ539149A (en) | 2007-05-31 |
| EP1542654A4 (en) | 2008-12-17 |
| JP2006508058A (ja) | 2006-03-09 |
| CA2499602A1 (en) | 2004-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20041844L (no) | Peptider som er effektive i behandlingen av tumorer og andre tilstander i forbindelse med fjerning eller odeleggelse av celler | |
| ATE376835T1 (de) | Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis | |
| CY1107531T1 (el) | Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου | |
| BRPI0513866A (pt) | composição, micropartìculas, método para o tratamento da hipertensão pulmonar, e dispositivo de inalação | |
| DE60327557D1 (de) | Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie | |
| DK0755249T3 (da) | Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom | |
| ATE415962T1 (de) | Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs | |
| NO20035231D0 (no) | Peptider som kan nyttes for behandling av tumorer og andre tilstander som krever fjerning eller destruksjon av celler | |
| WO2001056466A3 (en) | Method for evaluating novel stroke treatments using a tissue risk map | |
| DE60231050D1 (de) | Verwendung von Totarol zur Behandlung von Pruritus | |
| DK1368054T3 (da) | Anvendelse af neurale trådproteiner til behandling af tumorer | |
| DE60333488D1 (de) | Behandlung von Melanoma mittels p-aminobenzoesäure (PABA) | |
| TR200201724T2 (tr) | Antihipertansiyon ve buna bağlı belirtileri tedavi etmek için method ve formüller | |
| DE60237039D1 (de) | Verfahren zur behandlung von rosacea und telangiectasia | |
| NO20075695L (no) | Fremgangsmate til a behandle eller forhindre type-2 diabetes | |
| ATE402699T1 (de) | Verwendung von substituierten pyrazolen zur behandlung von allergien | |
| DE69902520D1 (de) | Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden | |
| WO2007123859A3 (en) | Method and device to inactivate and kill cells and organisms that are undesirable | |
| ATE211921T1 (de) | Verwendung von gonadotropin zur behandlung der gestartigen hypertrophie der prostata | |
| TR28228A (tr) | Deri gönlerinin islak muamelesi. | |
| DE69927286D1 (de) | Verwendung von humanen prostatazellinien zur behandlung von prostatakrebs | |
| DE602004009414D1 (de) | BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN MIT N-2,3,3-TETRAMETHYLBICYCLOi2.2.1öHEPTAN-2-AMINE | |
| DE69923559D1 (de) | Methoden zur inhibierung von helicobacter pylori | |
| ATE458495T1 (de) | Therapeutische zubereitung für autoimmune erkrankungen | |
| DE602005010258D1 (de) | Behandlung von ballastwasser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |